ロード中...
metabolic profiling of Parkinson's disease and mild cognitive impairment
Background: Early diagnosis of Parkinson's disease and mild cognitive impairment is important to enable prompt treatment and improve patient welfare, yet no standard diagnostic test is available. Metabolomics is a powerful tool used to elucidate disease mechanisms and identify potential biomark...
保存先:
| 出版年: | Mov Disord |
|---|---|
| 主要な著者: | , , , , , , , , , |
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
John Wiley and Sons Inc.
2017
|
| 主題: | |
| オンライン･アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5485028/ https://ncbi.nlm.nih.gov/pubmed/28394042 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/mds.26992 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|